Clinical trial NCT06118112: Living With Long COVID: LONGCOVID-EXPERIENCE
Official title: Living With Long COVID: LONGCOVID-EXPERIENCE Qualitative Study
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Long COVID
Experience, Life
Keywords: Post-Acute COVID-19 Syndrome
patient experience
qualitative research
Lead sponsor: Corporacion Parc Tauli
Sponsor class: OTHER
Collaborators: name: Universitat Autonoma de Barcelona
First posted: 2023-11-07
Enrollment: 25
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients treated at the Parc Taulí Hospital Universitari, a hospital with a reference population of 400,000 urban people and 4,500 workers.

Brief summary: Background: One in ten people infected with COVID-19 presents persistent COVID, which consists of the presence of symptoms three months after the acute manifestations of COVID-19 and their persistence for at least two months, without being explained by an alternative diagnosis. The characteristics and clinical approach to persistent COVID syndrome are fairly well known, but not what the experience of people with persistent COVID is in relation to their daily life, their work life, and their experience with the healthcare received. Objective: to understand the experience of patients with persistent COVID in relation to the disease, the health care received and re-entry into the world of work

Methods: Qualitative, descriptive, phenomenological study, based on individual interviews. The study protocol will be registered in Clinicaltrials.gov. People with persistent COVID treated at the Parc Taulí Hospital will be included. Sampling will be by convenience, purposive and snowball and the sample size will be determined by data saturation. Semi-structured individual or group interviews will be conducted and the data will be analyzed following a reflective thematic analysis (Brawn and Clarke). The preliminary report will be triangulated with some participants and with the results obtained from a scoping review carried out by the research team.


Eligibility criteria: Inclusion Criteria:

* women and men diagnosed with persistent COVID between March '20 to the present according to WHO criteria (persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis).
* treated at the Parc Taulí Hospital
* from 18 to 65 years

Exclusion Criteria:

-people who do not understand or can communicate in Catalan or Spanish.

Primary outcomes:
measure: Experience of the disease
timeFrame: Up to three years
measure: Experience with healthcare received
timeFrame: Up to three years
measure: Experience with return to work
timeFrame: Up to three years
Secondary outcomes:
Other outcomes:
Locations:
city: Sabadell
country: Spain
facility: Corporació Sanitària Parc Taulí
state: Barcelona
Study officials:
affiliation: Parc Taulí, Hospital Universitari- I3PT
name: Anna Selva, MD, MPH, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Universitat Autònoma Barcelona
name: Juan Leiva, PhD
role: STUDY_DIRECTOR
affiliation: Parc Taulí, Hospital Universitari- I3PT
name: Pilar Peña, MD
role: PRINCIPAL_INVESTIGATOR
References: